Comparative evaluation of PRRSV MLV vaccine efficacy administered via intranasal and intramuscular routes in early age of piglets

Early porcine reproductive and respiratory syndrome virus (PRRSV) infections in suckling pigs are commonly observed, emphasizing the need for early vaccination strategies. However, the effectiveness of early vaccination in suckling pigs remains debated due to potential interference from maternally derived antibodies (MDA) and the immature immune system of piglets. This study evaluated and compared protective efficacy and immune responses of intranasal (IN) and intramuscular (IM) administration of a commercial PRRSV-2 modified live virus (MLV) vaccine in 3-day-old piglets against a Thai highly pathogenic (HP)-PRRSV strain. Piglets from PRRSV-seropositive sows were randomly allocated to four groups: unvaccinated, unchallenged control (A-NEG); unvaccinated, HP-PRRSV-challenged control (B-POS); intramuscular vaccination with PRRSV-2 MLV (C-IM); intranasal vaccination with PRRSV-2 MLV (D-IN). At five weeks of age, piglets in the B-POS, C-IM, and D-IN groups were challenged with HP-PRRSV. Following challenge with HP-PRRSV, both C-IM and D-IN groups demonstrated significant reductions in fever and improved growth performance compared to the B-POS group. Notably, the C-IM group exhibited lower viral loads in the tracheobronchial lymph nodes (TBLN), while the D-IN group showed significantly reduced viral loads in the tonsils. As expected, neutralizing antibody against HP-PRRSV was low across all groups. Interestingly, the D-IN group exhibited enhanced systemic T lymphocyte responses, characterized by increased numbers of PRRSV-specific IFN-γ<sup>+</sup>-producing CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes following viral challenge. Early vaccination of piglets with PRRSV-2 MLV effectively reduced clinical signs and improved growth performance during HP-PRRSV infection, regardless of the administration route. Notably, intranasal vaccination induced higher PRRSV-specific T lymphocytes responses, highlighting its potential as an alternative strategy for early vaccination in piglets. These findings underscore the importance of optimizing vaccination protocols to improve PRRSV control measures in swine farms, particularly against early PRRSV infections.

Authors

Institutions

Publication Details

Journal
Vaccine
Published
2025-10-01
DOI
https://doi.org/10.1016/j.vaccine.2025.127822
Citations
1
Primary Topic
Animal Virus Infections Studies
Type
article
Field-Weighted Citation Impact
1.19
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative evaluation of PRRSV MLV vaccine efficacy administered via intranasal and intramuscular routes in early age of piglets

Chaitawat Sirisereewan, Sawang Kesdangsakonwut, Yonlayong Woonwong, Teerawut Nedumpun et al.
1 citations
Vaccine
Animal Virus Infections Studies
1.19
article

Comparative evaluation of PRRSV MLV vaccine efficacy administered via intranasal and intramuscular routes in early age of piglets

Chaitawat Sirisereewan, Sawang Kesdangsakonwut, Yonlayong Woonwong, Teerawut Nedumpun, Roongroje Thanawongnuwech, Apichart Prapattanakullawong, Rafa Boonprakob, Ousakorn Kamenkit
article en
1 citations

Abstract

Early porcine reproductive and respiratory syndrome virus (PRRSV) infections in suckling pigs are commonly observed, emphasizing the need for early vaccination strategies. However, the effectiveness of early vaccination in suckling pigs remains debated due to potential interference from maternally derived antibodies (MDA) and the immature immune system of piglets. This study evaluated and compared protective efficacy and immune responses of intranasal (IN) and intramuscular (IM) administration of a commercial PRRSV-2 modified live virus (MLV) vaccine in 3-day-old piglets against a Thai highly pathogenic (HP)-PRRSV strain. Piglets from PRRSV-seropositive sows were randomly allocated to four groups: unvaccinated, unchallenged control (A-NEG); unvaccinated, HP-PRRSV-challenged control (B-POS); intramuscular vaccination with PRRSV-2 MLV (C-IM); intranasal vaccination with PRRSV-2 MLV (D-IN). At five weeks of age, piglets in the B-POS, C-IM, and D-IN groups were challenged with HP-PRRSV. Following challenge with HP-PRRSV, both C-IM and D-IN groups demonstrated significant reductions in fever and improved growth performance compared to the B-POS group. Notably, the C-IM group exhibited lower viral loads in the tracheobronchial lymph nodes (TBLN), while the D-IN group showed significantly reduced viral loads in the tonsils. As expected, neutralizing antibody against HP-PRRSV was low across all groups. Interestingly, the D-IN group exhibited enhanced systemic T lymphocyte responses, characterized by increased numbers of PRRSV-specific IFN-γ<sup>+</sup>-producing CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes following viral challenge. Early vaccination of piglets with PRRSV-2 MLV effectively reduced clinical signs and improved growth performance during HP-PRRSV infection, regardless of the administration route. Notably, intranasal vaccination induced higher PRRSV-specific T lymphocytes responses, highlighting its potential as an alternative strategy for early vaccination in piglets. These findings underscore the importance of optimizing vaccination protocols to improve PRRSV control measures in swine farms, particularly against early PRRSV infections.

VaccineVol. 65
Chulalongkorn University (TH), Kasetsart University (TH), Department of Livestock Development (TH)
Openalex Percentile: Top 19%
Animal Virus Infections Studies
1.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.